Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Nolan Sean P.
Chief Executive Officer at Taysha Gene Therapies. Filing since 20 May 2021.
CIK 0001569926
Company
Date
Role
Action
Shares
Amount
Of holding
TSHA
Taysha Gene Therapies, Inc.
26 Jan 2026
Chief Executive Officer
Sold at will
41,312
$190.45K
1.4%
TSHA
Taysha Gene Therapies, Inc.
23 Jan 2026
Chief Executive Officer
Sold at will
136,789
$649.75K
4.4%
TSHA
Taysha Gene Therapies, Inc.
16 Aug 2023
Chief Executive Officer
Bought
444,444
$400.00K
40.7%
TSHA
Taysha Gene Therapies, Inc.
20 May 2021
Director
Bought
1,170
$26.15K
opened
4 decisions on file.
